Stock listing
BX Swiss:6ML Molecular Partners AG Aktie
Swiss listing (BX Swiss) of Molecular Partners AG · home listing SIX Swiss:MOLN
Follow Molecular Partners AG into a list and get an email when it puts out news.
Home listing price · SIX:MOLN
2.89 CHF -0.10 (-3.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:MOLN
- Day range
- 2.88 – 3.00 CHFOct 30, 2026
- Volume
- 20,215 sharesOct 30, 2026
- Market cap
- 110.7M CHFAt the close on Oct 30, 2026 · price × 38.31M shares outstanding
- 52-week range
- 2.66 – 3.96 CHFLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- 48,179 CHFMedian day 11,023 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:MOLN · Home | 2.89 CHF | -0.10 (-3.3%) | 20,215 | 3.00 | 3.00 | 2.88 | 2.99 | Close on Oct 30, 2026 |
| NASDAQ:MOLN | $3.81 USD | +0.14 (+3.8%) | 1,896 | $3.65 | $3.81 | $3.603 | $3.67 | Close on Oct 27, 2026 |
| OTC:MLLCF | $4.01 USD | 0.00 (0.0%) | — | $4.01 | $4.01 | $4.01 | $4.01 | Close on Oct 27, 2026 |
| LSE:0QXX | 3.00 CHF | +0.04 (+1.4%) | 2,000 | 3.00 | 3.00 | 3.00 | 2.96 | Close on Oct 23, 2026 |
| Frankfurt:6ML | €3.22 EUR | -0.24 (-6.9%) | — | €3.22 | €3.22 | €3.22 | €3.46 | Close on Oct 30, 2026 |
| Frankfurt:6ML0 | €3.08 EUR | -0.04 (-1.3%) | — | €3.10 | €3.12 | €3.06 | €3.12 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · SIX:MOLN · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 2.89 | -0.10 | -3.3% | 3.00 | 3.00 | 2.88 | 20,215 | |
| 2.99 | -0.01 | -0.3% | 3.00 | 3.04 | 2.94 | 23,626 | |
| 3.00 | -0.15 | -4.8% | 3.09 | 3.19 | 3.00 | 5,563 | |
| 3.15 | -0.02 | -0.6% | 3.17 | 3.21 | 3.15 | 9,518 | |
| 3.17 | +0.03 | +1.0% | 3.03 | 3.17 | 3.00 | 19,203 | |
| 3.14 | +0.11 | +3.6% | 3.00 | 3.14 | 2.98 | 3,562 | |
| 3.03 | -0.01 | -0.3% | 3.06 | 3.06 | 2.93 | 28,362 | |
| 3.04 | -0.01 | -0.3% | 3.07 | 3.09 | 3.04 | 2,897 | |
| 3.05 | -0.01 | -0.3% | 3.08 | 3.10 | 3.04 | 10,957 | |
| 3.06 | -0.04 | -1.3% | 3.07 | 3.14 | 3.04 | 17,872 | |
| 3.10 | -0.05 | -1.6% | 3.13 | 3.13 | 3.09 | 5,055 | |
| 3.15 | +0.07 | +2.3% | 3.01 | 3.20 | 2.99 | 23,282 | |
| 3.08 | -0.15 | -4.6% | 3.20 | 3.20 | 3.08 | 32,604 | |
| 3.23 | +0.04 | +1.3% | 3.17 | 3.23 | 3.12 | 19,461 | |
| 3.19 | -0.02 | -0.6% | 3.32 | 3.32 | 3.15 | 14,862 | |
| 3.21 | -0.10 | -3.0% | 3.33 | 3.33 | 3.21 | 2,708 | |
| 3.31 | -0.02 | -0.6% | 3.27 | 3.31 | 3.20 | 11,800 | |
| 3.33 | +0.02 | +0.6% | 3.33 | 3.37 | 3.23 | 5,580 | |
| 3.31 | +0.06 | +1.8% | 3.30 | 3.36 | 3.29 | 4,973 | |
| 3.25 | -0.08 | -2.4% | 3.49 | 3.49 | 3.25 | 7,457 | |
| 3.33 | -0.01 | -0.3% | 3.49 | 3.49 | 3.33 | 11,970 | |
| 3.34 | +0.02 | +0.6% | 3.30 | 3.34 | 3.27 | 3,288 | |
| 3.32 | +0.01 | +0.3% | 3.29 | 3.36 | 3.24 | 5,821 | |
| 3.31 | +0.01 | +0.3% | 3.32 | 3.32 | 3.22 | 5,790 | |
| 3.30 | +0.08 | +2.5% | 3.27 | 3.38 | 3.22 | 16,312 | |
| 3.22 | -0.18 | -5.3% | 3.38 | 3.49 | 3.22 | 27,047 | |
| 3.40 | +0.04 | +1.2% | 3.34 | 3.40 | 3.32 | 2,948 | |
| 3.36 | -0.04 | -1.2% | 3.38 | 3.38 | 3.31 | 8,643 | |
| 3.40 | 0.00 | 0.0% | 3.38 | 3.40 | 3.26 | 2,212 | |
| 3.40 | -0.06 | -1.7% | 3.46 | 3.46 | 3.26 | 4,761 | |
| 3.46 | +0.21 | +6.5% | 3.27 | 3.46 | 3.24 | 19,977 | |
| 3.25 | +0.04 | +1.2% | 3.27 | 3.27 | 3.21 | 1,801 | |
| 3.21 | -0.16 | -4.7% | 3.35 | 3.35 | 3.19 | 8,329 | |
| 3.37 | +0.10 | +3.1% | 3.29 | 3.37 | 3.20 | 15,295 | |
| 3.27 | -0.06 | -1.8% | 3.31 | 3.31 | 3.25 | 3,825 | |
| 3.33 | -0.06 | -1.8% | 3.37 | 3.37 | 3.31 | 1,484 | |
| 3.39 | -0.07 | -2.0% | 3.44 | 3.44 | 3.25 | 14,831 | |
| 3.46 | +0.04 | +1.2% | 3.40 | 3.46 | 3.33 | 4,427 | |
| 3.42 | +0.08 | +2.4% | 3.46 | 3.46 | 3.35 | 8,286 | |
| 3.34 | -0.15 | -4.3% | 3.47 | 3.49 | 3.30 | 18,858 | |
| 3.49 | -0.01 | -0.3% | 3.48 | 3.49 | 3.45 | 5,889 | |
| 3.50 | +0.11 | +3.2% | 3.41 | 3.56 | 3.39 | 12,044 | |
| 3.39 | -0.03 | -0.9% | 3.56 | 3.56 | 3.30 | 17,579 | |
| 3.42 | -0.15 | -4.2% | 3.64 | 3.64 | 3.42 | 26,934 | |
| 3.57 | -0.06 | -1.7% | 3.65 | 3.68 | 3.50 | 16,553 | |
| 3.63 | -0.12 | -3.2% | 3.77 | 3.85 | 3.63 | 35,335 | |
| 3.75 | +0.15 | +4.2% | 3.64 | 3.79 | 3.60 | 75,345 | |
| 3.60 | +0.19 | +5.6% | 3.41 | 3.64 | 3.41 | 46,988 | |
| 3.41 | -0.12 | -3.4% | 3.53 | 3.53 | 3.30 | 27,355 | |
| 3.53 | +0.04 | +1.1% | 3.48 | 3.54 | 3.48 | 10,076 | |
| 3.49 | 0.00 | 0.0% | 3.47 | 3.50 | 3.45 | 17,294 | |
| 3.49 | +0.01 | +0.3% | 3.48 | 3.54 | 3.45 | 27,466 | |
| 3.48 | +0.02 | +0.6% | 3.40 | 3.48 | 3.40 | 33,113 | |
| 3.46 | +0.06 | +1.8% | 3.45 | 3.46 | 3.40 | 8,755 | |
| 3.40 | +0.03 | +0.9% | 3.39 | 3.45 | 3.39 | 17,600 | |
| 3.37 | +0.14 | +4.3% | 3.39 | 3.39 | 3.35 | 11,023 | |
| 3.23 | -0.03 | -0.9% | 3.26 | 3.30 | 3.21 | 12,168 | |
| 3.26 | -0.02 | -0.6% | 3.26 | 3.28 | 3.22 | 10,760 | |
| 3.28 | +0.01 | +0.3% | 3.39 | 3.39 | 3.23 | 3,724 | |
| 3.27 | +0.03 | +0.9% | 3.22 | 3.29 | 3.21 | 4,858 | |
| 3.24 | -0.01 | -0.3% | 3.22 | 3.25 | 3.22 | 1,565 | |
| 3.25 | -0.03 | -0.9% | 3.34 | 3.38 | 3.25 | 13,513 | |
| 3.28 | -0.06 | -1.8% | 3.32 | 3.32 | 3.24 | 1,030 | |
| 3.34 | -0.02 | -0.6% | 3.38 | 3.38 | 3.27 | 6,713 | |
| 3.36 | +0.03 | +0.9% | 3.35 | 3.41 | 3.28 | 30,071 | |
| 3.33 | -0.01 | -0.3% | 3.32 | 3.38 | 3.30 | 6,004 | |
| 3.34 | +0.09 | +2.8% | 3.27 | 3.38 | 3.23 | 27,142 |
- Ticker
- BX Swiss:6ML
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Oct 29, 2026
Molecular Partners Reports Q3 2026 Financial Results, Deepens Focus on Targeted Radiotherapy
Latest deck · Oct 29, 2026
Investor Presentation (October 2026)
Investor deck · 38 slides
Calls
Replays
Molecular Partners (SIX Swiss: MOLN) Q2 2024 Earnings Call
Tue, Aug 27, 2024 · 8:00 AM ET
Watch TranscriptMolecular Partners (SIX Swiss: MOLN) Q4 2023 Earnings Call
Fri, Mar 15, 2024 · 8:00 AM ET
Watch TranscriptMolecular Partners (SIX Swiss: MOLN) Q4 2022 Earnings Call
Fri, Mar 10, 2023 · 11:00 AM ET
Watch Transcript
Latest news
Molecular Partners Reports Q3 2026 Financial Results, Deepens Focus on Targeted Radiotherapy
Oct 29, 2026
Closed 2.99 (-0.3%) on Oct 29, 2026
Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study
Aug 25, 2026
Closed 3.41 (-3.4%) on Aug 25, 2026
Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
Jul 16, 2026
Closed 3.24 (-0.3%) on Jul 16, 2026
Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference
Jul 15, 2026
Closed 3.25 (+2.8%) on Jul 15, 2026
Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics
Jul 6, 2026
Closed 3.20 (+0.6%) on Jul 6, 2026
Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712
Jul 2, 2026
Closed 3.20 (+3.2%) on Jul 2, 2026
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
May 30, 2026
Closed 3.17 (+1.0%) on Jun 1, 2026
Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit
May 26, 2026
Closed 3.15 (+2.3%) on May 27, 2026
Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317
May 12, 2026
Closed 3.01 (-4.1%) on May 13, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 38 slides · Oct 29, 2026
H1 2026 Earnings Presentation
Earnings · 40 slides · Aug 25, 2026
SNMMI 2025
Conference · 12 slides · Jun 24, 2025
EANM 2024
Conference · 10 slides · Oct 22, 2024
Molecular Partners AG on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 42 in all · newest Oct 29, 2026 · oldest 2025
- Calls
- 3 calls with a replay · 3 with a transcript · latest Aug 27, 2024
- Decks
- 10 decks · latest Oct 29, 2026
Where Molecular Partners AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:MOLN · Home listing | SIX Swiss | Switzerland | CHF |
| NASDAQ:MOLN | NASDAQ | United States | USD |
| Lang & Schwarz:A12DEH | Lang & Schwarz | Germany | EUR |
| LS Exchange:A12DEH | LS Exchange | Germany | EUR |
| OTC:MLLCF | OTC | United States | USD |
| LSE:0QXX | LSE | United Kingdom | CHF |
| gettex:6ML | gettex | Germany | EUR |
| BX Swiss:6ML · This page | BX Swiss | Switzerland | CHF |
| gettex:6ML0 | gettex | Germany | EUR |
| Aquis:MOLNZ | Aquis | United Kingdom | CHF |
| BOATS:MOLN | BOATS | United States | USD |
| Dusseldorf:6ML0 | Dusseldorf | Germany | EUR |
| Frankfurt:6ML | Frankfurt | Germany | EUR |
| Frankfurt:6ML0 | Frankfurt | Germany | EUR |
| Hamburg:6ML | Hamburg | Germany | EUR |
| Lang & Schwarz:A3CSB5 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3CSB5 | LS Exchange | Germany | EUR |
| Munich:6ML | Munich | Germany | EUR |
| Munich:6ML0 | Munich | Germany | EUR |
| Stuttgart:6ML | Stuttgart | Germany | EUR |
| Stuttgart:6ML0 | Stuttgart | Germany | EUR |
| Tradegate:6ML0 | Tradegate | Germany | EUR |
| Turquoise:MOLNZ | Turquoise | United Kingdom | CHF |
Log in to ask 6ix AI your own questions about Molecular Partners AG.